CYTOMEGALOVIRUS IgG AND IgM ANTIBODIES AMONG SUDANESE PATIENTS WITH ACUTE MYELOID LEUKEMIA: RELATION TO HEMATOLOGICAL PROGNOSTIC MARKERS
DOI:
https://doi.org/10.5455/ijcbr.2017.33.03Abstract
Background: Viral oncogenesis has remained an area of interest in cancer biology. Viruses have been great tutors of cancer biology, helping researchers to uncouple many signaling pathways and identifying critical therapeutic targets. Aim: The aim of this study was to assess the incidence of cytomegalovirus (CMV) infection and its impact on hematological prognostic markers of Acute Myeloid Leukemia (AML) among Sudanese populations. Method: The seroprevlance of CMV infection in AML patients was assessed in 100AML and 100 age and gender-matched controls. The associations of total white cell count and absolute blast count with the seroprevlance were examined. Results: The prevalence of CMV infection was 81% in patients and 17% in control subjects. Total white cell count and blast count were higher in AML CMV positive patients than AML CMV negative patients. Conclusion: Our findings indicate a high incidence of CMV infections in AML and its worse association with hematological markers could emphasize the role of CMV in the progression of AML.
KEYWORDS: Acute myeloid leukemia; Cytomegalovirus.
Downloads
Downloads
Published
Issue
Section
License
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.